The EC/ACP/WHO Partnership on Pharmaceutical Policies. Highlights of Year 5
(2010; 8 pages)

Abrégé
Established in March 2004, the EC/ACP/WHO Partnership on Pharmaceutical Policies has committed €25 million to the strategic and technical support of 78 African, Caribbean and Pacific Island (ACP) countries in the development and implementation of essential medicines strategies. The ultimate aim of the programme is to save lives and improve the health of the population of ACP countries by increasing the availability and affordability of essential medicines and ensuring acceptable standards of drug quality, safety and use. Looking back on the achievements of the previous five years, there is no doubt that the EC/ACP/WHO Partnership has led to significant changes in the management of essential medicines within ACP countries that will save lives and improve the overall health of the population. Year 5 (from 30 September 2008 to 1 October 2009) proved to be a particularly successful period with the finalization of many projects, tools and guidelines and the effective implementation of a wide range of specific strategic objectives as determined within each country. The table on the right indicates the results areas where the most significant progress was made in the first five years of the Partnership; with the number of countries achieving the target often surpassing, even reaching double, what was projected. A summary of achievements in selected areas is provided...
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019